Key result
EPO gene polymorphisms are linked to increased risk of diabetic retinopathy in type 2 diabetes.
Why the study?
The association of EPO (rs551238, rs1617640) and TCF7L2 (rs7903146) gene polymorphisms with diabetic retinopathy in the Northern Chinese population was unclear.
Case-Control (n=680)
EPO (rs551238, rs1617640) genotypes are susceptible genes for diabetic retinopathy in Chinese type 2 diabetic patients.
Objective: For studying the association of EPO (rs551238), EPO (rs1617640), and TCF7L2 (rs7903146) gene with diabetic retinopathy in Northern Chinese population. Methods: We conducted a case-control study, which enrolled 680 subjects and performed SNP genotyping and calculated allele frequencies. Results: When comparison was performed between DR patients and normal persons, the EPO (rs551238) AA genotype has a significant risk association with DR, and AC genotype has a significant protective association with DR. The EPO (rs551238) A allele has a significant risk association with DR, and C allele has a significant protective association with DR. When comparison was performed between DR patients and DM patients, the EPO (rs551238) CC genotype has a significant protective association with DR; the EPO (rs551238) A allele has a significant risk association with DR; and C allele has a significant protective association with DR. When comparison was performed between DR patients and normal persons, the EPO (rs1617640) GT genotype has a significant protective association with DR, and TT genotype has a significant risk association with DR. The EPO (rs1617640) G allele has a significant protective association with DR, and T allele has a significant risk association with DR. In addition, we found that TT genotype does not exist in rs7903146 of TCF7L2 in Chinese population so that the data could not be used. Conclusions: EPO (rs551238, rs1617640) genotype is a susceptible gene for DR in Chinese type 2 diabetic patients, especially the high-risk PDR.
No takes yet. Share an insight, caveat, or question.
Bai et al. (2022) conducted a case-control in Diabetic Retinopathy (n=680). EPO (rs551238), EPO (rs1617640), and TCF7L2 (rs7903146) gene polymorphisms vs. Normal persons and diabetic patients without retinopathy was evaluated on Association with diabetic retinopathy. EPO (rs551238 and rs1617640) gene polymorphisms were significantly associated with the risk of diabetic retinopathy in Chinese type 2 diabetic patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: